The SOS Steering Committee is made up of distinguished peers of the pharmaceutical and science communities, chosen for their expertise in stability research and innovation. We are proud to introduce this year’s seven members.
Jean-René Authelin, Ph.D.
Senior Scientific Advisor for Global CMC Development, Sanofi S.A.
Steven W. Baertschi, Ph.D., FAAPS
President, Baertschi Consulting LLC
Sanjay Konagurthu, Ph.D.
Senior Director, Science and Innovation, Thermo Fisher Scientific
Christian Laue, Ph.D.
Principal Scientist and Laboratory Head in Analytical Development, Merck Healthcare KGaA
Anthony Mazzeo, Ph.D.
Associate Scientific Director of Analytical Strategy and Operations, Bristol Myers Squibb
Garry Scrivens, Ph.D.
Associate Research Fellow, Pfizer (UK)
Kenneth C. Waterman, Ph.D.
President, FreeThink Technologies LLC
SOS 2022 Program
The SOS 2022 program is currently in development, and there are a limited number of full-length, featured speaking opportunities available to those who are interested. To be considered, please submit a presentation topic with the speaker’s information to Carolyn Rothfeld.